Although the role of NKCC2 in renal handling of glucose remains poorly defined, NKCC2AKO mice developed several aspects of MetS including increased basal glycemia, glucose intolerance and insulin resistance (Kelly et al., 2019), but not hypertension, at least when mice were young (Oppermann et al., 2007). The gene discussed is SLC12A1; the disease is Insulin resistance.